Paradromics Achieves Real-Time Speech with Connexus® Brain-Computer Interface
On Sept. 14, 2026, Paradromics, a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform designed to restore…
-
-
Biotechnology | FDA | Imaging | Neurology
FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara
On Sept. 14, 2026, Telix today announces that the U.S. Food and Drug Administration (FDA) has approved its…
-
Pennsylvania Department of Health Reports Measles Outbreak Cases Reach 676 in 37 Counties
On Sept. 11, 2026, the Pennsylvania Department of Health (DOH) announced that 676 measles cases have been confirmed…
-
Michael J. Fox Foundation for Parkinson’s Research Receives Lasker~Bloomberg Public Service Award
On Sept. 10, 2026, Lasker~Bloomberg Public Service Award honors Michael J. Fox (Michael J. Fox Foundation for Parkinson’s…
-
Tom Golisano Commits $225 Million to Six Additional Children’s Hospitals, Expanding Golisano Children’s Alliance to 21 Members Nationwide
On Sept. 10, 2026, philanthropist and entrepreneur Tom Golisano announced a $225 million investment in six children’s hospitals,…
-
Lonza Further Strengthens U.S. Manufacturing Presence with Addition of Spray-Drying Facility in Bend, Oregon
On Sept. 10, 2026, Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced plans to further…
-
Lasker~DeBakey Clinical Medical Research Award Recognizes hemophilia A Treatment
On Sept. 9, 2026, the Albert Lasker~DeBakey Clinical Medical Research Award honored three scientists for inventing a bispecific…
-
WHO prequalifies multi-dose RSV vaccine vial, paving the way to protecting more infants globally
On Sept. 9, 2026, the World Health Organization (WHO) announced it has prequalified the multi-dose vial presentation of…
-
Emmanuel Mignot and Masashi Yanagisawa Receive Albert Lasker Basic Medical Research Award
On Sept. 9, 2026, the Albert Lasker Basic Medical Research Award honors two physician scientists for the identification…
-
Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms
On Sept. 8, 2026, Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for the…
-
Scientists identify new role for tau protein in brain diseases
On Sept. 8, 2026, researchers from the National Institutes of Health (NIH) found that hyperphosphorylated tau activates reverse…
-
Google DeepMind Launches AlphaGenome Atlas: A predictive map of every possible DNA letter change in the human genome
On Sept. 8, 2026, Google DeepMind released the AlphaGenome Atlas: a platform containing predictions for the effects of…
-
Artificial Intelligence | Biotechnology | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology
U.S. Research Cuts Drive Scientists to Germany
On Sept. 8, 2026, Science funding cuts in the United States have led many researchers to seek out…
-
UCLA scientists engineer ready-to-use cancer-fighting T cells for solid tumors
On Sept. 8, 2026, researchers from the University of California, Los Angeles (UCLA) announce they have developed a…
-
Study Reveals How Toilet Aerosols Reach the Breathing Zone
On Sept. 8, 2026, researchers from Flinders University have found that flushing toilets can release aerosols and bioaerosols…
-
FDA Grants Accelerated Approval to AstraZeneca’s New Breast Cancer Treatment
On Sept. 4, 2026, the U.S. Food and Drug Administration (FDA) announced they have expanded treatment options for…
-
Scientists Complete Full Map of the Fruit Fly Central Nervous System
On Sept. 3, 2026, Janelia scientists and collaborators announced they have completed a wiring diagram of the central…
-
ZANVASTRO™ (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) in pediatric and adult patients
On Sept. 3, 2026, Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO™…
-
University of California San Diego Study Report expanded DNA alphabet
On Sept. 2, 2026, researchers at University of California San Diego have demonstrated that one of biology’s most…
-
Congo’s Ebola outbreak shows no signs of slowing as deaths top 3,000
On Sept. 2, 2026, the Associated Press reports that Congo’s Ebola outbreak has killed more than 3,000 people…
-
Atlas of the brain’s striatum could guide researchers to new drug treatments
On Sept. 1, 2026, Massachusetts Institute of Technology (MIT) researchers release a study that reveals insights into populations…
-
Vertex Completes Acquisition of Crinetics Pharmaceuticals for $10 Billion
On Sept. 1, 2026, Vertex Pharmaceuticals announced the successful completion of the acquisition of Crinetics Pharmaceuticals, a global…
-
Researchers Discover Dozens of Genes Tied to OCD and Tic Disorders
On Aug. 31, 2026, a Rutgers-led international collaboration has identified 36 genes that substantially raise the risk for…
-
White House Announces Deal with Nine Mid-Size Pharmacutical Companies to Lower Drug Prices
On Aug. 31, 2026, the White House announced agreements with nine- mid-sized pharmaceutical manufacturers to lower prescription drug…
-
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases for $2.875 billion in cash
On Aug. 31, 2026, Eli Lilly and Merida Biosciences, a biotechnology company advancing a new class of precision…
-
Northwestern to launch $30 million center to unlock genome’s hidden code
On Aug. 28, 2026, the U.S. National Science Foundation (NSF) announced it has awarded Northwestern University $30 million…
-
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Oncology | Pharmaceutical | Therapeutics
Scientists Decode Gene Circuits of Human Immunity, Fueling New Era of Disease Research
On Aug. 28, 2026, scientists from Gladstone Institutes, UC San Francisco, and Stanford University, in collaboration with Biohub,…
-
Scientific American ranks states by kindergarten vaccination rates
On Aug. 28, 2026, America’s kindergartners are heading back to school less vaccinated than ever. New Centers for…
-
Global initiative launched to improve access to mpox vaccines
On Aug. 27, 2026, a global initiative to establish a stockpile of mpox vaccines was launched creating a…
-
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
On Aug. 27, 2026, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) has approved…
